Related Experiment Video
Updated: Dec 29, 2025

05:07
Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles
Published on: March 18, 2019
6.7K
An Efficient and Cost-Effective Nose-Only Inhalational Chamber for Rodents: Design, Optimization and Validation
Ranjot Kaur1,2, Anupama Kaushik3, Kamalinder K Singh2
1University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Studies, Panjab University, Chandigarh, 160 014, India.
AAPS Pharmscitech
|January 29, 2020
Summary
Researchers developed a cost-effective, mouse-specific inhalation chamber for pulmonary drug delivery. This device reliably generates aerosolized medication for direct lung targeting in rodent models, aiding respiratory research.
Area of Science:
- Pulmonary Drug Delivery
- Inhalation Toxicology
- Rodent Models in Research
Background:
- Pulmonary disorders are often treated with inhaled medications delivered via nebulizers or inhalers.
- Existing rodent inhalers are expensive and require significant maintenance, hindering laboratory-scale research.
- There is a need for accessible and reliable systems for inhalational drug delivery in small animal models.
Purpose of the Study:
- To develop a simple, cost-effective, and reliable nose-only inhalation chamber for three mice.
- To characterize the aerosol properties and drug delivery efficiency of the developed system.
Main Methods:
- A novel nose-only inhalation chamber was designed and constructed for simultaneous exposure of three mice.
- Laser diffraction and next-generation impactor studies were used to analyze aerosol particle size (volume mean diameter and mass aerodynamic diameter).
- Voriconazole (VRC) delivery efficiency and lung deposition in mice were quantified using in vivo nebulization studies.
Main Results:
- The inhalation chamber successfully generated an aerosol cloud for rodent inhalation.
- Particle size analysis showed a volume mean diameter of 4.02 ± 0.30 μm and a mass aerodynamic diameter of 3.40 ± 0.27 μm.
- Approximately 2.05 ± 0.20 mg of voriconazole was available per port, with 76.12 ± 19.50 μg deposited in mouse lungs after 20 minutes of nebulization.
Conclusions:
- The developed nose-only inhalation chamber provides a reliable and affordable method for aerosol generation and exposure in mice.
- This system facilitates effective pulmonary drug delivery and lung deposition in a rodent model.
- The device is suitable for laboratory-scale research in pulmonary disorders and inhalation toxicology.

